These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 26022131

  • 1. Selection of a novel DNA thioaptamer against HER2 structure.
    Hu Y, Duan J, Cao B, Zhang L, Lu X, Wang F, Yao F, Zhu Z, Yuan W, Wang C, Yang XD.
    Clin Transl Oncol; 2015 Aug; 17(8):647-56. PubMed ID: 26022131
    [Abstract] [Full Text] [Related]

  • 2. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
    Liu Z, Duan JH, Song YM, Ma J, Wang FD, Lu X, Yang XD.
    J Transl Med; 2012 Jul 20; 10():148. PubMed ID: 22817844
    [Abstract] [Full Text] [Related]

  • 3. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
    Sett A, Borthakur BB, Bora U.
    Clin Transl Oncol; 2017 Aug 20; 19(8):976-988. PubMed ID: 28224267
    [Abstract] [Full Text] [Related]

  • 4. SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells.
    Wang M, Wu H, Duan M, Yang Y, Wang G, Che F, Liu B, He W, Li Q, Zhang L.
    Life Sci; 2019 Sep 01; 232():116663. PubMed ID: 31323275
    [Abstract] [Full Text] [Related]

  • 5. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX.
    Dastjerdi K, Tabar GH, Dehghani H, Haghparast A.
    Biotechnol Appl Biochem; 2011 Sep 01; 58(4):226-30. PubMed ID: 21838796
    [Abstract] [Full Text] [Related]

  • 6. Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy.
    Jeong HY, Kim H, Lee M, Hong J, Lee JH, Kim J, Choi MJ, Park YS, Kim SC.
    Int J Mol Sci; 2020 Dec 21; 21(24):. PubMed ID: 33371333
    [Abstract] [Full Text] [Related]

  • 7. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
    Liu M, Wang Z, Tan T, Chen Z, Mou X, Yu X, Deng Y, Lu G, He N.
    Theranostics; 2018 Dec 21; 8(20):5772-5783. PubMed ID: 30555580
    [Abstract] [Full Text] [Related]

  • 8. Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer.
    Zhu G, Zhang H, Jacobson O, Wang Z, Chen H, Yang X, Niu G, Chen X.
    Bioconjug Chem; 2017 Apr 19; 28(4):1068-1075. PubMed ID: 28122449
    [Abstract] [Full Text] [Related]

  • 9. Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding.
    Mahlknecht G, Maron R, Schechter B, Yarden Y, Sela M.
    Biochem Biophys Res Commun; 2015 Sep 18; 465(2):218-24. PubMed ID: 26248137
    [Abstract] [Full Text] [Related]

  • 10. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
    Lu M, Zhou L, Zheng X, Quan Y, Wang X, Zhou X, Ren J.
    Cancer Biomark; 2015 Sep 18; 15(2):163-70. PubMed ID: 25519016
    [Abstract] [Full Text] [Related]

  • 11. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.
    Li X, Zhang W, Liu L, Zhu Z, Ouyang G, An Y, Zhao C, Yang CJ.
    Anal Chem; 2014 Jul 01; 86(13):6596-603. PubMed ID: 24892693
    [Abstract] [Full Text] [Related]

  • 12. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL, Peng H, Wang Z, Tyrrell GJ, Li XF, Le XC.
    Methods; 2016 Mar 15; 97():51-7. PubMed ID: 26678795
    [Abstract] [Full Text] [Related]

  • 13. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
    Mahlknecht G, Sela M, Yarden Y.
    Methods Mol Biol; 2015 Mar 15; 1317():3-15. PubMed ID: 26072398
    [Abstract] [Full Text] [Related]

  • 14. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.
    Thiel KW, Hernandez LI, Dassie JP, Thiel WH, Liu X, Stockdale KR, Rothman AM, Hernandez FJ, McNamara JO, Giangrande PH.
    Nucleic Acids Res; 2012 Jul 15; 40(13):6319-37. PubMed ID: 22467215
    [Abstract] [Full Text] [Related]

  • 15. Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein.
    Kang J, Lee MS, Copland JA, Luxon BA, Gorenstein DG.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):1835-9. PubMed ID: 18294846
    [Abstract] [Full Text] [Related]

  • 16. Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An in silico assessment.
    Niazi S, Purohit M, Sonawani A, Niazi JH.
    J Mol Graph Model; 2018 Aug 15; 83():112-121. PubMed ID: 29902673
    [Abstract] [Full Text] [Related]

  • 17. Selection of DNA aptamers for capture and detection of Salmonella Typhimurium using a whole-cell SELEX approach in conjunction with cell sorting.
    Dwivedi HP, Smiley RD, Jaykus LA.
    Appl Microbiol Biotechnol; 2013 Apr 15; 97(8):3677-86. PubMed ID: 23494620
    [Abstract] [Full Text] [Related]

  • 18. Improved Detection of HER2 by a Quasi-Targeted Proteomics Approach Using Aptamer-Peptide Probe and Liquid Chromatography-Tandem Mass Spectrometry.
    Zhou W, Xu F, Li D, Chen Y.
    Clin Chem; 2018 Mar 15; 64(3):526-535. PubMed ID: 29142051
    [Abstract] [Full Text] [Related]

  • 19. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL, Peng H, Wang Z, Newbigging AM, Tyrrell GJ, Li XF, Le XC.
    J Mol Evol; 2015 Dec 15; 81(5-6):194-209. PubMed ID: 26538121
    [Abstract] [Full Text] [Related]

  • 20. Enhanced Human Epidermal Growth Factor Receptor 2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs.
    Lee H, Dam DH, Ha JW, Yue J, Odom TW.
    ACS Nano; 2015 Oct 27; 9(10):9859-67. PubMed ID: 26335372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.